脑部放疗剂量对脑与头颈肿瘤患者早期自评认知功能的影响
研究纳入2012至2021年接受放疗的110例原发脑肿瘤与356例头颈肿瘤患者,采用患者报告结局量表评估基线及1年认知功能。脑肿瘤患者基线与1年认知功能评分均显著较低(p<0.001)。多因素分析显示年龄≤65岁、较高基线认知评分及脑平均剂量>3 Gy为认知功能恶化的显著预测因素。
要点
- 脑肿瘤患者基线与1年认知功能评分均显著低于头颈肿瘤患者(p<0.001)。
- 多因素分析中年龄≤65岁、较高基线认知评分、脑平均剂量>3 Gy为认知恶化的显著预测因素。
- 单因素分析中接受化疗及左右海马多个剂量水平也与认知恶化统计学相关。
核心结论
- 本研究识别了主观认知下降的风险因素,并提示患者自感知的认知恶化可能与年龄、基线认知评分及脑部放疗剂量超过3 Gy相关。
研究设计与样本
- 纳入2012至2021年接受放疗的原发脑肿瘤与头颈肿瘤患者,收集基线及1年随访时的患者特征、临床参数与患者报告结局量表。
- 共纳入110例脑肿瘤患者与356例头颈肿瘤患者,脑肿瘤患者中位年龄56岁,头颈肿瘤患者中位年龄67.5岁。
- 使用EORTC QLQ-C30的认知功能评分、QLQ-BN20的沟通障碍评分及EQ6D中1个认知相关问题,后两者仅用于脑肿瘤患者。
- 对缺失数据进行插补,将四点量表评分转换为百分制,并将基线至1年的评分变化分为改善/稳定或恶化。
- 危及器官通过临床勾画或回顾性自动勾画完成,并计算危及器官剂量。
主要发现
- 脑肿瘤患者基线与1年认知功能评分均显著较低(p<0.001)。
- 认知功能变化单因素分析显示,开始放疗时年龄≤65岁、接受化疗、较高基线认知功能评分、脑平均剂量>3 Gy以及左右海马多个剂量水平与认知恶化统计学相关。
- 认知功能变化多因素分析确定年龄≤65岁、较高基线认知功能评分及脑平均剂量>3 Gy为显著预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Assess cognitive changes after radiotherapy (RT) in brain and head-and-neck (HN) cancer patients using patient-reported outcome measures (PROMs) and evaluate a dose-effect relationship for brain structures. MATERIALS AND METHODS: Primary brain and HN cancer patients treated with RT between 2012-2021 were included. Patient characteristics, clinical parameters, and PROMs at baseline and 1-year follow-up were collected. Cognitive functioning (CF) from the EORTC QLQ-C30, communication deficit (CD) from the QLQ-BN20, and one cognition-related questions from the EQ6D questionnaire were used, the latter two only for brain patients. Missing data were imputed and the four-point scale scores were transformed to a 100-point scale. Change in scores from baseline to 1-year were categorized into improvement/constant or deterioration. Organs-at-risk (OARs) were contoured either clinically or retrospectively using autocontouring and dose to the OARs were calculated. RESULTS: A total of 110 brain and 356 HN cancer patients were included. Median age was 56 (brain) and 67.5 (HN) years. Baseline and 1-year CF was significantly lower for brain patients (p < 0.001). Univariate analysis for ΔCF showed that age at start RT ≤ 65 years, receiving chemotherapy, higher CF Baseline score, brain mean dose > 3 Gy, and multiple dose levels to left and right hippocampus were statistically associated with cognitive deterioration. Multivariate analysis for ΔCF identified age at RT ≤ 65 years, higher CF Baseline score, and brain mean dose > 3 Gy as significant predictors. CONCLUSION: This study identified risk factors for subjective cognitive decline and suggests that patients' self-perceived cognitive deterioration may be related to age, CF baseline score and brain radiation dose above 3 Gy.
引用
- Vaassen F, Hofstede D, Zegers CML, et al. The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patients. Clin Transl Radiat Oncol. 2025. PMID: 40028425. doi:10.1016/j.ctro.2025.100929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。